ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (2026 K)

Article Toolbox
  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bbamcr.2008.03.012    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2008 Elsevier B.V. All rights reserved.

High content analysis of γ-secretase activity reveals variable dominance of presenilin mutations linked to familial Alzheimer's disease

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Cristina Floreana, b, Enrico Zampesea, Marion Zaneseb, c, Lucia Brunelloa, François Ichasb, c, Francesca De Giorgib, c and Paola Pizzoa, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment Biomedical Sciences and CNR Institute of Neuroscience, University of Padua, Via G. Colombo, 3, 35121 Padua, Italy

bINSERM U916, VINCO, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux, France

cFLUOFARMA, 2 rue Robert Escarpit, 33600 Pessac, France


Received 9 January 2008; 
revised 11 March 2008; 
accepted 12 March 2008. 
Available online 3 April 2008.

Abstract

γ-Secretase mediates the intramembranous proteolysis of amyloid precursor protein (APP), Notch and other cellular substrates and is considered a prime pharmacological target in the development of therapeutics for Alzheimer's disease (AD). We describe here an efficient, new, simple, sensitive and rapid assay to quantify γ-secretase activity in living cells by flow cytometry using two membrane-bound fluorescent probes, APP-GFP or C99-GFP, as substrates for γ-secretase. The principle of the assay is based on the fact that the soluble intracellular domain of GFP-tagged APP (AICD-GFP) is released from the membrane into the cytosol following γ-secretase cleavage. Using this feature, enzymatic activity of γ-secretase could be deduced from the extent of the membrane retention of the probe observed after plasma membrane permeabilization and washout of the cleaved fraction. By applying two well-known γ-secretase inhibitors (DAPT and L-685,458), we validated our assay showing that the positional GFP-based probes for γ-secretase activity behave properly when expressed in different cell lines, providing the basis for the further development of a high-throughput and high content screening for AD targeted drug discovery. Moreover, by co-expression of different familial AD-linked mutated forms of presenilin – the key component of the γ-secretase complex – in cells devoid of any endogenous γ-secretase, our method allowed us to evaluate in situ the contribution of different presenilin variants to the modulation of the enzyme.

Keywords: γ-Secretase assay; Alzheimer's disease; Presenilin; High content analysis; Recombinant probe; Automated flow cytometry

Article Outline

1. Introduction
2. Materials and methods
2.1. Reagents
2.2. Plasmids construction
2.3. Cell lines and transfection
2.4. Western blotting
2.5. Confocal microscopy
2.6. Flow cytometry
2.7. Apoptosis measurement
3. Results
3.1. Biochemical characterization of the recombinant GFP-based probes for γ-secretase activity
3.2. Intracellular distribution of GFP probes upon γ-secretase activity
3.3. Detecting γ-secretase activity by flow cytometry
3.4. Using the GFP probes, to analyze FAD-linked PSs effect on γ-secretase activity
4. Discussion
Acknowledgements
References










Corresponding Author Contact InformationCorresponding author. Tel.: +39 049 8276067; fax: +39 049.8276049.

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.